Loading clinical trials...

Clinicopathological Parameters of HER2 Low Breast Cancers | Clinical Trials | Clareo Health

COMPLETEDNCT06433804

Clinicopathological Parameters of HER2 Low Breast Cancers

This was a retrospective cohort study which included all histologically proven cases of breast cancer in the 2 years from January 2022- December 2023 at a tertiary care centre. This study was perform...

Lead sponsor: Vardhman Mahavir Medical College And Safdarjung Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment70

Start dateJan 2022

Last updatedMay 30, 2024

Condition

HER2 Low Breast Cancers

Locations shown

VMMC SJH

New Delhi

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 30, 2024Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions